FDA clears blood test to aid evaluation for Alzheimer's disease
- Alzheimer: 14 events in the last 90 days
What happened
The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.
Summary assembled by rule from the sources below